Accessibility Menu
Cv Sciences logo

Cv Sciences(OTC) CVSI

Current Price$0.02
Market Cap$4.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-96%
5 Year-94%
1 Year-48%
1 Month-9%
Cv Sciences last closing stock price
MetricPriceDate
Last closeUSD 0.022026-07-22
Cv Sciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.84%USD 0.022026-07-15
1 month-9.02%USD 0.022026-06-22
3 month-33.96%USD 0.032026-04-23
Year to date-66.66%USD 0.062025-12-31
1 year-48.41%USD 0.042025-07-22
3 year-58.5%USD 0.052023-07-21
5 year-93.6%USD 0.322021-07-23
Since inception-96.14%USD 0.532011-11-09

Cv Sciences Financials at a Glance

Market Cap

$4.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$13.38M

Net Income (TTM)

-$1.49M

EPS (TTM)

-$0.01

P/E Ratio

-2.56

Dividend

$0.00

Beta (Volatility)

0.66 (Low)

Price

$0.02

Volume

305,777

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.10

Estimated Earnings Date

May 11, 2026

CVSI News

Foolcom-Featured.png

CV Sciences Sales Down 10 Percent

Motley Fool Markets TeamAug 13, 2025
Man Holding Marijuana Plant Leaves in Hands Getty

The 9 Best Marijuana Stocks in October

Sean WilliamsNov 6, 2019
Cannabis Oil CBD Pot Weed Marijuana Medical THC Getty

Quietly, CV Sciences Is Succeeding in a Competitive CBD Market

Sean WilliamsOct 23, 2019
NYSE Wall Street Trading New York Financial Stock Market Getty

3 Marijuana Stocks That Should Uplist to the Nasdaq or NYSE Next

Sean WilliamsOct 9, 2019
Cannabis Flower Up Close Pot Weed Marijuana Grow Farm THC Getty

5 of the Cheapest Pot Stocks Under $5

Sean WilliamsOct 5, 2019
Beta definition with green marker

The 3 Least-Volatile Pot Stocks on the Market

Keith SpeightsSep 26, 2019
legal-illegal-marijuana-leafs-on-dice-with-letters-getty

Is the U.S. Getting on Board With Cannabis Legalization?

Cory RenauerSep 1, 2019
doctor-holding-marijuana-cannabis-pot-weed-leaf-medical-getty

Better CBD Stock: Charlotte's Web vs. CV Sciences

Cory RenauerAug 20, 2019
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cv Sciences

CV Sciences makes plant-based supplements and hemp-based CBD products for people and pets. Its products help with daily wellness, stress, and nutrition needs. The company also develops plant-based foods and explores treatments for tobacco addiction.

Products and Services

  • CBD Supplements: Softgels, tinctures, gummies, and topicals for adults (PlusCBD).
  • Pet CBD Products: CBD oils and chews for pets (PlusCBD Pet).
  • Plant-Based Foods: Meat alternatives and snacks for consumers in Europe and the U.S. (Cultured Foods, Lunar Fox).
  • Non-CBD Supplements: Cannabinoid-free wellness products (PlusHLTH; launched 2024).
  • Pharmaceutical Development: Research on CBD and nicotine combination for tobacco addiction (CVSI-007; program dormant).

Growth and Expansion

  • Acquired Cultured Foods (Europe) in December 2023 to enter plant-based foods.
  • Acquired Elevated Softgels (U.S.) in May 2024 to expand manufacturing.
  • Launched Lunar Fox (U.S. plant-based foods) in January 2025.
  • Introduced PlusHLTH (non-CBD supplements) in 2024.
  • Expanded distribution in North America and Europe, with manufacturing in the U.S. and Poland.

What Makes CV Sciences Stand Out

The company operates in both North America and Europe, serving retail and online customers. It emphasizes scientific research, third-party testing, and flexible manufacturing for small and large orders. Its product launches and acquisitions support a diverse portfolio across supplements and foods.

Five Things You Need to Know

  • 2025 net product sales were $13.8 million, down 12.2% from 2024.
  • Gross margin improved to 49.0% in 2025, up from 45.6% in 2024.
  • Operating loss was $470,000 in 2025, improved from $2.2 million in 2024.
  • 39% of 2025 revenue came from new products launched since 2023.

Bottom Line

CV Sciences has shifted from a CBD focus to a broader plant-based wellness and food company. Its adaptability and new product launches reflect ongoing efforts to diversify and manage industry challenges.

AI Generated • Apr 16, 2026

Industry

Personal Products

Sector

Consumer Staples

Employees

44

CEO

Joseph D. Dowling, CPA

Website

www.cvsciences.com

Headquarters

San Diego, CA 92121, US

CVSI Financials

Key Financial Metrics (TTM)

Gross Margin

49.75%

Operating Margin

-9.87%

Net Income Margin

-11.15%

Return on Equity

-94.61%

Return on Capital

-32.24%

Return on Assets

-22.20%

Earnings Yield

-39.06%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

203.98M

Volume

305.78K

Avg. Volume

665.48K

Financials (TTM)

Gross Profit

$6.66M

Operating Income

-$1.32M

EBITDA

-$950.00K

Operating Cash Flow

-$225.00K

Capital Expenditure

-$72.00K

Free Cash Flow

-$297.00K

Cash & ST Invst.

$309.00K

Total Debt

$1.49M

Cv Sciences Performance Analysis

Cv Sciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 16,205,000-19.2%
20232023-12-31USD 16,004,000-1.2%
20242024-12-31USD 15,705,000-1.9%
20252025-12-31USD 13,789,000-12.2%
Cv Sciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-300.4%
Q32025-09-30-10.1%
Q42025-12-311.6%
Q12026-03-31-3.4%
Cv Sciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.07-54.1%
20232023-12-31USD 0.02N/A
20242024-12-31USD -0.01N/A
20252025-12-31USD -0.01-61.8%
Cv Sciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-133.3%
Q32025-09-30-50.0%
Q42025-12-3147.6%
Q12026-03-31-209.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$3.20M

-11.4%

Gross Profit

$1.56M

-5.8%

Gross Margin

48.89%

N/A

Market Cap

$4.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$88.84K

N/A

Employees

47

N/A

Net Income

-$643.00K

-489.9%

EBITDA

-$295.00K

-417.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$309.00K

-61.9%

Total Debt

$1.49M

-2.2%

Accounts Receivable

$391.00K

-9.1%

Inventory

$3.90M

-10.7%

Long Term Debt

$37.00K

-94.0%

Short Term Debt

$1.45M

+59.7%

Return on Assets

-22.20%

N/A

Return on Invested Capital

-85.67%

N/A

Free Cash Flow

$98.00K

+181.0%

Operating Cash Flow

$101.00K

+224.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BUDZWEED, Inc.
$0.02-33.33%
HYEXHealthy Extracts Inc.
$0.91-27.46%
DHBUFDelivra Health Brands Inc.
$0.07+21.60%
CBIHCannabis Bioscience International Holdings, Inc.
$0.00-50.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.28-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.96-0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.94+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$70.28-0.02%

Questions About CVSI

What is the current price of Cv Sciences?

Cv Sciences is trading at $0.02 per share.

What is the 52-week range for Cv Sciences?

Over the past 52 weeks, Cv Sciences has traded between $0.02 and $0.10.

How much debt does Cv Sciences have?

As of the most recent reporting period, Cv Sciences reported total debt of $1.49M.

How much cash does Cv Sciences have on hand?

Cv Sciences reported $309.00K in cash and cash equivalents in its most recent financial results.

What is Cv Sciences’s dividend yield?

Cv Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services